Butterfly Network

Butterfly Network
Name	Butterfly Network
Type	Public
Industry	Medical devices
Founded	2011
Founders	Jonathan Rothberg
Headquarters	Guilford, Connecticut, United States
Key people	Amy Roberts (CEO)
Products	Handheld ultrasound devices, Butterfly iQ, Butterfly iQ+
Revenue	(2023)
Employees	(2023)

Butterfly Network

Butterfly Network is a medical imaging company that developed a handheld ultrasound device integrating semiconductor technology with cloud software to enable point-of-care imaging. The company intersects the histories of Jonah Rosenberg-era startup ventures, translational efforts at academic institutions such as Massachusetts General Hospital, and commercialization trends exemplified by firms like GE Healthcare and Philips. Its trajectory involves interactions with investors including Tiger Global Management, regulatory bodies such as the U.S. Food and Drug Administration, and clinical users from institutions like Mayo Clinic and Johns Hopkins Hospital.

History

Founded in 2011 by entrepreneurs from biotechnology and computational fields, the company emerged amid a surge of interest from venture capital firms including SoftBank Vision Fund and Viking Global Investors. Early development drew on research networks associated with Yale School of Medicine and engineering collaborators from Stanford University. The company's commercialization phase paralleled public offerings by peers such as Siemens Healthineers and strategic movements in the medtech sector after mergers like Abbott Laboratories' acquisitions. Key historical milestones include prototype demonstrations at conferences like Radiological Society of North America and strategic hires from firms including Amazon and Google.

Products and Technology

The company's flagship devices combine microchip-based ultrasound transducers with mobile software, marketed under names such as the Butterfly iQ ecosystem. The technology leverages advances in CMOS analog design and semiconductor fabrication similar to suppliers for Intel and Texas Instruments. The product line integrates with smartphone and tablet platforms from Apple Inc. and Samsung Electronics, and supports cloud workflows compatible with picture archiving and communication systems used by Epic Systems and Cerner Corporation. The software stack uses artificial intelligence approaches championed by research groups at Massachusetts Institute of Technology and Carnegie Mellon University to drive image interpretation, similar in ambition to efforts by IBM Watson Health. Accessories and enterprise offerings target hospitals and clinics comparable to Cleveland Clinic deployments and telemedicine programs run by Teladoc Health.

Clinical Applications and Research

Clinicians have applied the handheld ultrasound devices in settings from emergency departments at Charité – Universitätsmedizin Berlin to obstetrics clinics associated with University of California, San Francisco. Published studies in journals such as The Lancet, JAMA, and Radiology examined performance in lung, cardiac, abdominal, and vascular imaging compared with cart-based systems from Philips and GE Healthcare. Research collaborations involved academic centers including Harvard Medical School, University of Pennsylvania, and Stanford School of Medicine, and randomized trials mirrored designs seen in trials sponsored by National Institutes of Health and Wellcome Trust. Clinical applications extended to low-resource contexts in partnerships with nongovernmental organizations like Doctors Without Borders and initiatives supported by the Bill & Melinda Gates Foundation.

Business and Funding

The company’s funding history includes rounds led by investors such as Baillie Gifford, Fidelity Investments, and strategic participation from technology investors paralleling placements by Palantir Technologies and NVIDIA. A notable financing milestone was a public listing that resembled the market entries of contemporaries like Teladoc Health and Moderna. Revenue and capital allocation decisions reflected competitive dynamics with established medical device manufacturers including Siemens and disruptive entrants like AliveCor. Corporate development activities involved supply-chain agreements with electronics manufacturers tied to Foxconn and distribution partnerships mirroring routes used by McKesson Corporation and Cardinal Health.

Regulatory Approvals and Safety

Regulatory clearances were sought from agencies including the U.S. Food and Drug Administration and notified bodies in the European Union. The firm navigated pathways akin to those used by diagnostic device makers such as Roche Diagnostics and Abbott Laboratories, addressing safety standards defined in guidance from International Electrotechnical Commission and clinical payload requirements cited by World Health Organization. Post-market surveillance and adverse event reporting practices aligned with expectations set in enforcement actions involving companies like Medtronic and Theranos-era scrutiny, prompting emphasis on clinical validation and user training in hospital systems such as Mount Sinai Health System.

Market Reception and Partnerships

Market reception encompassed adoption by emergency medicine groups at Brigham and Women's Hospital and primary care networks associated with Kaiser Permanente, while enterprise contracts involved collaborations with distributors like Baxter International and software integrators used by Siemens Healthineers. Strategic partnerships included pilot programs with telehealth providers such as Amwell and research alliances with universities like Columbia University. The company’s competitive positioning was compared with entrants like Fujifilm and specialized startups backed by Sequoia Capital and Andreessen Horowitz, shaping procurement decisions among health systems including Intermountain Healthcare.

Category:Companies based in Connecticut Category:Medical device companies of the United States